XOMA Corporation stock is up 15.65% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 37 February’s closed higher than January. 100% of analysts rate it a buy.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets with commercial sales potential.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!